Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)
Autor: | Pascal Vranckx, Yoshinobu Onuma, Olivier F. Bertrand, Tian Hai Koh, Robert-Jan van Geuns, Rodrigo Modolo, Osama Ibrahim Ibrahim Soliman, Rui Cruz Ferreira, Chun Chin Chang, Aris Moschovitis, Marco Valgimigli, Sing-Chien Yap, Stephen P. Hoole, Hidenori Komiyama, Christian W. Hamm, Amanda G. M. R. Sousa, Azfar Zaman, Philippe Gabriel Steg, Patrick W. Serruys, Tommaso Gori, Peter Jüni, Ernest Spitzer, Kuniaki Takahashi, Bernhard Frey, Stephan Windecker, Mariusz Tomaniak, Ply Chichareon, Norihiro Kogame |
---|---|
Přispěvatelé: | Graduate School, ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation, ACS - Heart failure & arrhythmias, Cardiology |
Rok vydání: | 2019 |
Předmět: |
Male
Ticagrelor Internationality medicine.medical_treatment Myocardial Infarction Kaplan-Meier Estimate 030204 cardiovascular system & hematology Coronary Angiography HSM CAR Aspirin / therapeutic use law.invention Electrocardiography 0302 clinical medicine Randomized controlled trial law Silent Myocardial Infarction Clinical endpoint Electrocardiography / methods Prospective Studies 030212 general & internal medicine Myocardial infarction 610 Medicine & health education.field_of_study Myocardial Infarction / diagnostic imaging Drug-Eluting Stents Middle Aged Prognosis Treatment Outcome Cardiology Drug Therapy Combination Female Cardiology and Cardiovascular Medicine medicine.medical_specialty Population Myocardial Infarction / mortality Risk Assessment Statistics Nonparametric 03 medical and health sciences Percutaneous Coronary Intervention Multicenter trial Internal medicine medicine Humans Percutaneous Coronary Intervention / mortality cardiovascular diseases Ticagrelor / therapeutic use education Coronary Angiography / methods Aged Asymptomatic Diseases / mortality Analysis of Variance Aspirin business.industry Percutaneous coronary intervention medicine.disease Survival Analysis Percutaneous Coronary Intervention / methods Asymptomatic Diseases Conventional PCI Myocardial Infarction / therapy business |
Zdroj: | American journal of cardiology, 124(12), 1833-1840. Elsevier Inc. Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação instacron:RCAAP American Journal of Cardiology, 124(12), 1833-1840. Elsevier Inc. |
ISSN: | 1879-1913 0002-9149 |
Popis: | Q-wave myocardial infarction (QWMI) comprises 2 entities. First, a clinically evident MI, which can occur spontaneously or be related to a coronary procedure. Second, silent MI which is incidentally detected on serial electrocardiographic (ECG) assessment. The prevalence of silent MI after percutaneous coronary intervention (PCI) in the drug-eluting stent era has not been fully investigated. The GLOBAL LEADERS is an all-comers multicenter trial which randomized 15,991 patients who underwent PCI to 2 antiplatelet treatment strategies. The primary end point was a composite of all-cause death or nonfatal new QWMI at 2-years follow-up. ECGs were collected at discharge, 3-month and 2-year visits, and analyzed by an independent ECG core laboratory following the Minnesota code. All new QWMI were further reviewed by a blinded independent cardiologist to identify a potential clinical correlate by reviewing clinical information. Of 15,968 participants, ECG information was complete in 14,829 (92.9%) at 2 years. A new QWMI was confirmed in 186 (1.16%) patients. Transient new Q-waves were observed in 28.5% (53 of 186) of them during the follow-up. The majority of new QWMI (78%, 146 of 186) were classified as silent MI due to the absence of a clinical correlate. Silent MI accounted for 22.1% (146 of 660) of all MI events. The prevalence of silent MI did not differ significantly between treatment strategies (experimental vs reference: 0.88% vs 0.98%, p = 0.5027). In conclusion, we document the prevalence of silent MI in an all-comers population undergoing PCI in this large-scale randomized trial. info:eu-repo/semantics/publishedVersion |
Databáze: | OpenAIRE |
Externí odkaz: |